カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の神経修復・再生市場2023-2030：手術別（神経移植術、神経縫合術）、製品別（生体材料神経刺激、神経調節機器）、地域別

【英語タイトル】Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Surgery (Nerve Grafting, Neurorrhaphy), By Product (Biomaterials Neurostimulation & Neuromodulation Device), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN078）・商品コード：GRV23JUN078
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月24日
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の神経修復・再生市場規模が、予測期間中（2023年～2030年）に年平均12.16％増加し、2030年までに205億ドルへ達すると見込まれています。本調査書では、神経修復・再生の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別（バイオシミラー、神経刺激・神経調節機器）分析、手術別（直接神経修復術／神経縫合術、神経移植術、幹細胞治療、神経刺激・神経調節手術）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競合分析などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、CYBERONICS, INC、MEDTRONIC、STRYKER、AXOGEN CORPORATION、ST. JUDE MEDICAL、BAXTER、BOSTON SCIENTIFIC CORPORATION、POLYGANICS、INTEGRA LIFESCIENCESなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界神経修復・再生の市場規模：製品別
- バイオシミラーの市場規模
- 神経刺激・神経調節機器の市場規模
・世界神経修復・再生の市場規模：手術別
- 直接神経修復術／神経縫合術の市場規模
- 神経移植術の市場規模
- 幹細胞治療の市場規模
- 神経刺激・神経調節手術の市場規模
・世界神経修復・再生の市場規模：地域別
- 北米の神経修復・再生市場規模
- ヨーロッパの神経修復・再生市場規模
- アジア太平洋の神経修復・再生市場規模
- 中南米の神経修復・再生市場規模
- 中東・アフリカの神経修復・再生市場規模
・競合分析

神経修復・再生市場の成長と動向

Grand View Research社の最新レポートによると、世界の神経修復・再生市場規模は2030年までに205億米ドルに達すると予測されています。2023年から2030年までのCAGRは12.16%で拡大する見込みです。罹患率の増加や神経疾患に関する意識の高まりに起因する神経疾患治療への需要が市場を促進するとみられます。さらに、政府の資金援助と償還政策、絶え間ない技術進歩が市場成長を後押しすると予測されています。

2016年1月、EUのHorizon 2020プログラムは、NUIゴールウェイの再生医療研究所（REMEDI）が立ち上げた研究プロジェクト「Autostem」に約673万米ドルの資金を提供しました。このプロジェクトは、旧来の伝統的技術を凌駕するロボット幹細胞製造工場を開発するものです。この技術は、がん、糖尿病、関節炎など、さまざまな病気に対する新しい治療法の可能性をもたらします。新興国の主要企業による研究開発と投資の増加も市場を促進しています。2018年7月、Stem Cells Australia（SCA）はMedical Research Future Fund（MRFF）から幹細胞研究のために300万米ドルを受け取りました。

さらに、政府や民間資金提供団体が、脳性麻痺に対する臍帯血注入における幹細胞（フェーズII）や、ヒトの末梢神経損傷を修復するための軸索融合技術を促進するためのポリエチレングリコール（PEG）薬剤の使用（フェーズI）など、さまざまな神経疾患に対する安全で効果的な治療法を開発するための臨床試験を実施しています。

さらに2017年10月、Stryker社はフランスの医療機器会社VEXIM社を買収しました。VEXIM社のポートフォリオは、Stryker社のインターベンショナルスパイン（IVS）ポートフォリオを補完するものです。この買収により、Stryker社は東欧、中東、アジア、中南米における販売チャネルを強化できます。2018年1月、Boston Scientific Corporationは、最初で唯一の脊髄刺激装置システムSpectra WaveWriterの米国FDA承認を取得しました。このシステムは知覚障害に基づく治療に使用されます。

神経修復・再生市場レポートハイライト

– 2022年には、中枢神経系（CNS）障害の症例の増加や、精神障害と利用可能な治療法に関する意識の高まりにより、神経調節・神経刺激装置製品セグメントが市場をリードしました。

– 脊椎の安定化と骨折の治癒を促進し、入院を減らすことができる生分解性ポリマーの開発と技術の進歩により、生体材料製品分野は予測期間中に最も速いCAGRで拡大すると予測されます。

– 2022年は、技術の進歩や新しい器具の登場により、北米が市場をリードしました。政府の取り組みや資金援助、脊髄や脳の損傷など中枢神経系の損傷事例の増加が、この地域の市場成長をもたらした主な要因のひとつです。

– アジア太平洋地域は、予測期間中に最も急成長する地域市場になると予想されます。老年人口の増加、技術の進歩、多くのアンメットメディカルニーズが地域市場を牽引する要因の一部です。

– ペプチドのカクテル、神経刺激技術、幹細胞の脳への注入など、患者を昏睡状態から回復させることに成功した技術を含む治療法の組み合わせが使用されるようになりました。

– このような複雑な取り組みを実現することを目的として、既存の医療機器と再生生物学的医薬品が組み合わされるようになりました。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (model 2)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective – 1
1.9.2 Objective – 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Landscape Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration & Growth Prospect Mapping
3.4 Regulatory Framework & Reimbursement Scenario
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing government fundings and reimbursements
3.5.1.2 Increasing incidences of the neurological disorders
3.5.1.3 Rising medical tourism
3.5.2 Market Restraint Analysis
3.5.2.1 Lack of awareness in the patients for treatment of nerve repair and regeneration
3.5.2.2 High cost of the treatment and unavailability of trained medical personnel
3.6 Business Environment Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.1.1 Bargaining power of buyers: Moderate
3.6.1.2 Bargaining power of suppliers: Low
3.6.1.3 Competitive rivalry: High
3.6.1.4 Threat of new entrants: Moderate
3.6.1.5 Threat of substitutes: Moderate
3.6.2 PESTEL Analysis
3.6.2.1 Political & legal landscape
3.6.2.2 Economic landscape
3.6.2.3 Social landscape
3.6.2.4 Technological landscape
3.6.2.5 Environmental landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Licensing & Partnership
Chapter 4 Nerve Repair And Regeneration Market: Product Analysis
4.1 Nerve Repair And Regeneration Product Market Share Analysis, 2022
4.2 Nerve Repair And Regeneration Product Market: Segment Dashboard:
4.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Product Segment
4.3.1 Biosimilars
4.3.1.1 Biosimilars market, 2018 – 2030 (USD Million)
4.3.2 Neurostimulation & Neuromodulation Devices
4.3.2.1 Spinal cord stimulation devices market, 2018 – 2030 (USD Million)
4.3.2.2. Deep brain stimulation devices market, 2018 – 2030 (USD Million)
4.3.2.3 Sacral nerve stimulation devices market, 2018 – 2030 (USD Million)
4.3.2.4 Vagus nerve stimulation devices market, 2018 – 2030 (USD Million)
4.3.2.5 Gastric electric stimulation devices market, 2018 – 2030 (USD Million)
Chapter 5 Nerve Repair And Regeneration Market: Surgery Analysis
5.1 Nerve Repair And Regeneration Surgery Market Share Analysis, 2022
5.2 Nerve Repair And Regeneration Surgery Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analyses, 2018 – 2030 For The Surgery
5.3.1 Direct Nerve Repair/Neurorrhaphy
5.3.1.1 Direct nerve repair/Neurorrhaphy market, 2018 – 2030 (USD Million)
5.3.2 Nerve Grafting
5.3.2.1 Nerve grafting market, 2018 – 2030 (USD Million)
5.3.3 Stem Cell Therapy
5.3.3.1 Stem cell therapy market, 2018 – 2030 (USD Million)
5.3.4 Neurostimulation & Neuromodulation Surgeries
5.3.4.1 Neurostimulation & neuromodulation surgeries market, 2018 – 2030 (USD Million)
Chapter 6 Nerve Repair And Regeneration Market: Regional Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Marketplace: Key Takeaways
6.3. North America
6.3.1. SWOT Analysis
6.3.2. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.3.3. U.S.
6.3.3.1. Country Dynamics
6.3.3.2. Country Variables
6.3.3.3. Competitive Landscape
6.3.3.4. Regulatory/Reimbursement Framework
6.3.3.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.3.4. Canada
6.3.4.1. Country Dynamics
6.3.4.2. Country Variables
6.3.4.3. Competitive Landscape
6.3.4.4. Regulatory/Reimbursement Framework
6.3.4.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. SWOT Analysis
6.4.2. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.3. UK
6.4.3.1. Country Dynamics
6.4.3.2. Country Variables
6.4.3.3. Competitive Landscape
6.4.3.4. Regulatory/Reimbursement Framework
6.4.3.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.4. Germany
6.4.4.1. Country Dynamics
6.4.4.2. Country Variables
6.4.4.3. Competitive Landscape
6.4.4.4. Regulatory/Reimbursement Framework
6.4.4.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.5. France
6.4.5.1. Country Dynamics
6.4.5.2. Country Variables
6.4.5.3. Competitive Landscape
6.4.5.4. Regulatory/Reimbursement Framework
6.4.5.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.6. Italy
6.4.6.1. Country Dynamics
6.4.6.2. Country Variables
6.4.6.3. Competitive Landscape
6.4.6.4. Regulatory/Reimbursement Framework
6.4.6.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.7. Spain
6.4.7.1. Country Dynamics
6.4.7.2. Country Variables
6.4.7.3. Competitive Landscape
6.4.7.4. Regulatory/Reimbursement Framework
6.4.7.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Country Dynamics
6.4.8.2. Country Variables
6.4.8.3. Competitive Landscape
6.4.8.4. Regulatory/Reimbursement Framework
6.4.8.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.9. Sweden
6.4.9.1. Country Dynamics
6.4.9.2. Country Variables
6.4.9.3. Competitive Landscape
6.4.9.4. Regulatory/Reimbursement Framework
6.4.9.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.4.10. Norway
6.4.10.1. Country Dynamics
6.4.10.2. Country Variables
6.4.10.3. Competitive Landscape
6.4.10.4. Regulatory/Reimbursement Framework
6.4.10.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. SWOT Analysis
6.5.2. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5.3. Japan
6.5.3.1. Country Dynamics
6.5.3.2. Country Variables
6.5.3.3. Competitive Landscape
6.5.3.4. Regulatory/Reimbursement Framework
6.5.3.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5.4. China
6.5.4.1. Country Dynamics
6.5.4.2. Country Variables
6.5.4.3. Competitive Landscape
6.5.4.4. Regulatory/Reimbursement Framework
6.5.4.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5.5. India
6.5.5.1. Country Dynamics
6.5.5.2. Country Variables
6.5.5.3. Competitive Landscape
6.5.5.4. Regulatory/Reimbursement Framework
6.5.5.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5.6. Australia
6.5.6.1. Country Dynamics
6.5.6.2. Country Variables
6.5.6.3. Competitive Landscape
6.5.6.4. Regulatory/Reimbursement Framework
6.5.6.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5.7. Thailand
6.5.7.1. Country Dynamics
6.5.7.2. Country Variables
6.5.7.3. Competitive Landscape
6.5.7.4. Regulatory/Reimbursement Framework
6.5.7.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.5.8. South Korea
6.5.8.1. Country Dynamics
6.5.8.2. Country Variables
6.5.8.3. Competitive Landscape
6.5.8.4. Regulatory/Reimbursement Framework
6.5.8.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. SWOT Analysis
6.6.2. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.6.3. Brazil
6.6.3.1. Country Dynamics
6.6.3.2. Country Variables
6.6.3.3. Competitive Landscape
6.6.3.4. Regulatory/Reimbursement Framework
6.6.3.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.6.4. Mexico
6.6.4.1. Country Dynamics
6.6.4.2. Country Variables
6.6.4.3. Competitive Landscape
6.6.4.4. Regulatory/Reimbursement Framework
6.6.4.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.6.5. Argentina
6.6.5.1. Country Dynamics
6.6.5.2. Country Variables
6.6.5.3. Competitive Landscape
6.6.5.4. Regulatory/Reimbursement Framework
6.6.5.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. SWOT Analysis
6.7.2. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.7.3. South Africa
6.7.3.1. Country Dynamics
6.7.3.2. Country Variables
6.7.3.3. Competitive Landscape
6.7.3.4. Regulatory/Reimbursement Framework
6.7.3.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Country Dynamics
6.7.4.2. Country Variables
6.7.4.3. Competitive Landscape
6.7.4.4. Regulatory/Reimbursement Framework
6.7.4.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.7.5. UAE
6.7.5.1. Country Dynamics
6.7.5.2. Country Variables
6.7.5.3. Competitive Landscape
6.7.5.4. Regulatory/Reimbursement Framework
6.7.5.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
6.7.6. Kuwait
6.7.6.1. Country Dynamics
6.7.6.2. Country Variables
6.7.6.3. Competitive Landscape
6.7.6.4. Regulatory/Reimbursement Framework
6.7.6.5. Market estimates and forecast, 2016 – 2030 (Revenue, USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
7.3 Vendor Landscape
7.4 Public Companies
7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
7.5 Private Companies
7.5.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
7.6 Company Profiles
7.6.1 CYBERONICS, INC
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.1.5 SWOT Analysis
7.6.2 MEDTRONIC
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.2.5 SWOT Analysis
7.6.3 STRYKER
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.3.4 Strategic initiatives
7.6.3.5 SWOT Analysis
7.6.4 AXOGEN CORPORATION
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.4.4 Strategic initiatives
7.6.4.5 SWOT Analysis
7.6.5 ST. JUDE MEDICAL
7.6.5.1 Company overview
7.6.5.2 Financial performance
7.6.5.3 Product benchmarking
7.6.5.4 Strategic initiatives
7.6.5.5 SWOT Analysis
7.6.6 BAXTER
7.6.6.1 Company overview
7.6.6.2 Financial performance
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.6.5 SWOT Analysis
7.6.7 BOSTON SCIENTIFIC CORPORATION
7.6.7.1 Company overview
7.6.7.2 Financial performance
7.6.7.3 Product benchmarking
7.6.7.4 Strategic initiatives
7.6.7.5 SWOT Analysis
7.6.8 POLYGANICS
7.6.8.1 Company overview
7.6.8.2 Financial performance
7.6.8.3 Product benchmarking
7.6.8.4 Strategic initiatives
7.6.9 INTEGRA LIFESCIENCES
7.6.9.1 Company overview
7.6.9.2 Financial performance
7.6.9.3 Product benchmarking
7.6.9.4 Strategic initiatives
7.6.9.5 SWOT Analysis

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of Abbreviation
TABLE 3 List of players in North America
TABLE 4 List of players in Europe
TABLE 5 List of players in Asia Pacific
TABLE 6 List of players in Latin America
TABLE 7 List of players in MEA
TABLE 8 North America nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 9 North America nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 10 North America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 11 North America nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 12 U.S. nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 13 U.S. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 14 U.S. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 15 Canada. nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 16 Canada. nerve repair and regeneration market, by neurostimulation and neuromodulation devices 2018 - 2030 (USD Million)
TABLE 17 Canada nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 18 Europe nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 19 Europe nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 20 Europe nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 21 Europe nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 22 U.K. nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 23 U.K. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 24 U.K. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 25 Germany nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 26 Germany nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 27 Germany nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 28 France nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 29 France nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 30 France nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 31 Italy nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 32 Italy nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 33 Italy nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 34 Spain nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 35 Spain nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 36 Spain nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 37 Denmark nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 38 Denmark nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 39 Denmark nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 40 Sweden nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 41 Sweden nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 42 Sweden nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 34 Norway nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 43 Norway nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 44 Norway nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 45 Asia Pacific nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 47 Asia Pacific nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 48 Asia Pacific nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 49 Japan nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 50 Japan nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 51 Japan nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 52 China nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 53 China nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 54 China nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 55 India nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 56 India nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 57 India nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 58 Australia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 59 Australia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 60 Australia nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 61 South Korea nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 62 South Korea nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 63 South Korea nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 64 Thailand nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 65 Thailand nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 66 Thailand nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 67 Latin America nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 68 Latin America nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 69 Latin America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 70 Latin America nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 71 Brazil nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 72 Brazil nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 73 Brazil. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 74 Mexico nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 75 Mexico nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 76 Mexico nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 77 Argentina nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 78 Argentina nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 79 Argentina nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 80 MEA nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 81 MEA nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 82 MEA nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 83 MEA nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 84 South Africa nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 85 South Africa nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 86 South Africa nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 87 UAE nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 88 UAE nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 89 UAE nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 90 Saudi Arabia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 91 Saudi Arabia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 92 Saudi Arabia Nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 93 Kuwait nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 94 Kuwait nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 95 Kuwait Nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)

★調査レポート[世界の神経修復・再生市場2023-2030：手術別（神経移植術、神経縫合術）、製品別（生体材料神経刺激、神経調節機器）、地域別] (コード：GRV23JUN078)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経修復・再生市場2023-2030：手術別（神経移植術、神経縫合術）、製品別（生体材料神経刺激、神経調節機器）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の組織工学＆再生市場2023-2027
  • 世界の造影剤注入装置市場2023-2030：製品別（注入装置、消耗品）、種類別（シングルヘッド、デュアルヘッド）、用途別、エンドユーザー別、地域別
  • 世界の頭蓋内圧力モニタリング機器市場2023-2030：技術別（侵襲的、非侵襲的）、用途別（外傷性脳損傷、脳内出血）、地域別
  • 世界の神経刺激装置市場2023-2030：用途別（疼痛管理、パーキンソン病）、製品別（脊髄刺激装置、胃電気刺激装置）

    • ◆H&Iグローバルリサーチのお客様（例）◆